BioCare Systems News Release

BioCare to Present at Windhover Information and Medtech Insight's "Investment In Innovation" Conference

Parker, CO - (October 8, 2004) - BioCare Systems, Inc., will be presenting on Thursday, October 21st at Windhover Information and Medtech Insight's prestigious "Investment In Innovation" event, taking place October 21-22, 2004 at the Westin Copley Place Hotel in Boston, Mass.

BioCare Systems, Inc. (BioCare) develops and markets FDA cleared, innovative, practical, and non-invasive Low Level Light Therapy medical devices to decrease pain and accelerate healing.

Low Level Light Therapy, the medical device category that includes Light Emitting Diodes (LED) and laser technologies, is the application of red and near infrared light over injuries and lesions to improve wound/soft tissue healing and give relief for both acute and chronic pain. This promotes the body's own natural healing and tissue immune responses. In the clinical setting, Low Level Light Therapy has proven effective for many conditions to increase the speed, quality and tensile strength of tissue repair; give pain relief; resolve inflammation; and improve function of damaged neurological tissue.

BioCare has improved upon the proven technology of the science of photobiomodulation and developed a medical device for the consumer market using LED in place of laser technology. The company's patented emitter technology maximizes photobiomodulation with optimal dosage and wavelength parameters. Unique features of this technology control the output wavelength by regulating the temperature of the LED, allowing the energy to be absorbed by the body in a highly effective manner.

Research in Low Level Light Therapy by leading international scientists, including Dr. Harry Whelan of NASA and Dr. Tiina Karu, with the Russian Academy of Sciences, has determined that the stimulating effect of photon penetration and cell absorption, not the source of light (laser or LED), is the critical component to the biological results. Because LED light is safer, less expensive and as effective as the more highly complex technology used in clinical settings, using LED in place of laser technology enables a product to be successfully developed for the consumer market.

Researchers are currently investigating additional Low Level Light Therapy applications for spinal cord injuries, Parkinson disease, strokes, brain tumors and tissue, muscle and organ regeneration as well as healing wounds, ophthalmic applications and diabetic neuropathy.

BioCare has developed prototypes and FDA 510(k) K042532 approval is pending. The company anticipates the development and introduction of products targeted at the $32 billion therapeutic pain management market, of which the medical device segment is $719MM and growing at a rate of 9% per year. Product launch plans in the $3 billion minimally invasive cosmetic procedure market are included in the company's financial projections. Additional market opportunities have also been identified.

About Medtech Insight
Medtech Insight's "Investment In Innovation" conferences are considered the premier forum for senior executives in the investment and medical technology community to preview emerging medtech companies in need of funding, acquisition and/or strategic partnership.

About BioCare Systems, Inc.
Located in Denver, Colorado, BioCare Systems, Inc. (BioCare) develops and markets innovative, practical, non-invasive Low Level Light Therapy (LLLT) medical devices - FDA cleared to temporarily relieve pain for the widest range of indications - to consumers and to medical professionals whose patients want to maintain active lifestyles. BioCare is a leader in consumer LED Low Level Light Therapy through the application of sound science, marketplace knowledge, and the ability to mainstream complex clinical technology into affordable, effective, portable and easy-to-use products. For more information, visit www.biocaresystems.com or contact Sherry Fox, (303) 796-7043.

Contact

Sherry Fox
BioCare Systems, Inc.
(303) 796-7043
 
Bob Wolper
The Wolper Group
(303) 707-1021